Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01001039 · ClinicalTrials.gov registry record
Validation of the Facial and Cephalic Pain Inventory
A clinical trial of Sinusitis, sponsored by Greg Davis.
- Completed
- Registry status
- 68
- Enrollment target
- 1
- Study location
NCT01001039: Completed study of Sinusitis, sponsored by Greg Davis.
NCT01001039 is a study of Sinusitis that has completed, run by Greg Davis. The registered enrollment target is 68 participants, below the 125-participant average among 12 other Sinusitis trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01001039, a study of Sinusitis, has completed, sponsored by Greg Davis.
- COMPLETED
- Registry status
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
This study proposes to develop and validate a new instrument designed to measure facial and nasal discomfort related to chronic sinusitis. The second phase of the study will be to use this instrument to measure correlation with sinus computed tomography (CT) scans.
Conditions Studied
Study Locations (1)
Washington
- University of Washington Rhinology Clinic - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2009-10 |
| Est. Completion | 2012-06 |
What the finished NCT01001039 record still lists
NCT01001039 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 125-participant average among 12 other Sinusitis trials with a reported enrollment target (46% lower).
The record links to 1 condition, with Sinusitis appearing as the primary indexed condition, and to 0 interventions.
NCT01001039 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01001039 about?
NCT01001039 is a clinical study titled "Validation of the Facial and Cephalic Pain Inventory". This study proposes to develop and validate a new instrument designed to measure facial and nasal discomfort related to chronic sinusitis. The second phase of the study will be to use this instrument to measure correlation with sinus computed tomography (CT) scans.
What is the current status of trial NCT01001039?
This trial is currently completed. The enrollment target is 68 participants. The study started on 2009-10. Estimated completion is 2012-06.
What conditions does trial NCT01001039 study?
This clinical trial studies the following conditions: Sinusitis.
Who is sponsoring clinical trial NCT01001039?
This trial is sponsored by Greg Davis, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01001039 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sinusitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01001039's enrollment target sits among peer trials
68 6th of 12 higher than 6 of 12 other Sinusitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sinusitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
RECRUITING · NA
-
High Resolution Micro OCT Imaging
ACTIVE NOT RECRUITING
-
Dupixent Study for Alternate Administration
ACTIVE NOT RECRUITING · Phase 4
-
Reducing Antibiotic Use by Implementation of Stewardship in Primary and Urgent Care
ACTIVE NOT RECRUITING
-
A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To
COMPLETED · Phase 2
-
Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia